Weight loss ≥5% of initial body weight |
Significant reduction in systolic blood pressure, total cholesterol, low-density lipoprotein cholesterol, triglycerides, alanine aminotransferase (ALT), aspartate aminotransferase, and γ-glutamyl transferase in the adherent group (weight loss ≥5% of initial body weight) |
[13] |
Weight loss (≥7%) |
Weight loss is safe and improves liver histology and cardiometabolic profile, but it is only achieved in <50% of patients |
[16] |
Increasing or maintaining the level of physical activity in 150 min/week or more |
Greater improvement in levels of liver enzymes, independently of changes in weight |
[18] |
Complete a regular exercise program |
ALT normalization |
[19] |
Training exercises for 4 weeks |
Reduction in liver lipids in obese patients even in the absence of changes in body weight |
[20] |
Intensive lifestyle interventions |
Intensive lifestyle interventions were more effective than the prescription of dietary standard, both in weight loss and in liver enzymes |
[23] |
Review of the current management of pediatric NAFLD |
Lifestyle interventions should be the first line treatment for pediatric NAFLD. Vitamin E could be considered for those with non-alcoholic steatohepatitis (NASH) demonstrated by biopsy or those at risk for NASH where the first line therapy has failed. Other therapies require large RCTs in pediatric population |
[5] |